Relmada Therapeutics, Inc. (RLMD) Earnings
NASDAQ·Healthcare·Biotechnology
$3.27
+1.87%
Mkt Cap $358.41M
EPS — Estimate vs Actual
Mkt Cap
$358.41M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11
NASDAQ·Healthcare·Biotechnology
$3.27
+1.87%
Mkt Cap $358.41M
Mkt Cap
$358.41M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11